The role of tissue factor and protease-activated receptor 2 in endometriosis

American Journal of Reproductive Immunology

Volumn 68, Issue 3, 2012, Pages 251-257

  Lin, Min ^a   Weng, Huinan ^a   Wang, Xuefeng ^b   Zhou, Bing ^a   Yu, Ping ^a   Wang, Yifeng ^b  

^a GUANGZHOU MEDICAL UNIVERSITY   (China)

^b SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

Endometriosis; Menstrual cycle; Protease activated receptor 2; Tissue factor

Indexed keywords

MESSENGER RNA; PROTEINASE ACTIVATED RECEPTOR 2; THROMBOPLASTIN;

ADULT; ARTICLE; CONTROLLED STUDY; ENDOMETRIOSIS; ENDOMETRIUM TUMOR; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MENSTRUAL CYCLE; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS;

ADULT; CASE-CONTROL STUDIES; ENDOMETRIOSIS; ENDOMETRIUM; FEMALE; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; MENSTRUAL CYCLE; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTOR, PAR-2; RNA, MESSENGER; THROMBOPLASTIN;

EID: 84865291952     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/j.1600-0897.2012.01152.x     Document Type: Article

References (31)

1. Giudice LC, Kao LC: Endometriosis. Lancet 2004; 364:1789-1799.
2. Fraser IS: Mysteries of endometriosis pain: Chien-Ten Hsu Memorial Lecture 2009. J Obstet Gynaecol Res 2010; 36:1-10.
3. Bulletti C, Coccia ME, Battiston S, Borini A: Endometriosis and infertility. J Assist Reprod Genet 2010; 27:441-447.
4. Swiersz M: Role of endometriosis in cancer and tumor development. Ann N Y Acad Sci 2002; 955:281-292.
5. Munksgaard PS, Blaakaer J: The association between endometriosis and ovarian cancer: a review of histological, genetic and molecular alterations. Gynecol Oncol 2012; 124:164-169.
6. Kappou D, Matalliotakis M, Matalliotakis I: Medical treatments for endometriosis. Minerva Ginecol 2010; 62:415-432.
7. Petta CA, Ferriani RA, Abrao MS, Hessan D, Rosa E, Silva JC, Podgaec S, Bahamondes L: Randomized clinical trial of a levonorgestrel-releasing intrauterine system and a depot GnRH analogue for the treatment of chronic pelvic pain in women with endometriosis. Hum Reprod 2005; 20:1993-1998.
8. Schaffner F, Ruf W: Tissue factor and PAR2 signaling in the tumor microenvironment. Arterioscler Thromber Vasc Biol 2009; 29:1999-2004.
9. Ruf W, Yokota N, Schaffner F: Tissue factor in cancer progression and angiogenesis. Thromb Res 2010; 125(Suppl 2):S36-S38.
10. Schaffner F, Versteeg HH, Schillert A, Yokota N, Petersen LC, Mueller BM, Ruf W: Cooperation of tissue factor cytoplasmic domain and PAR2 signaling in breast cancer development. Blood 2010; 116:6106-6113.
11. Krikum G, Schatz F, Taylor H, LockWood CJ: Endometriosis and Tissue Factor. Ann N Y Acad Sci 2008; 1127:101-105.
12. Liu X, Nie J, Guo SW: Elevated immunoreactivity to tissue factor and its association with dysmenorrhea severity and the amount of menses in adenomyosis. Hum Reprod 2010; 26:337-345.
13. Fan L, Yotov WV, Zhu T, Esmalizadeh L, Joyal JS, Sennlaub F, Heveker N, Chemtob S, Rivard GE: Tissue factor enhances protease-activated receptor-2 mediated factor VIIa cell proliferative properties. J Thromb Haemost 2005; 3:1056-1063.
14. Hirota Y, Osuga Y, Hirata T, Harada M, Morimoto C, Yoshino O, Koga K, Yano T, Tsutsumi O, Taketani Y: Activation of protease -activated receptor 2 stimulates proliferation and interleukin(IL)-6 and IL-8 secretion of endometriotic stromal cells. Hum Reprod 2005; 20:3547-3553.
15. Juhasz-Böss I, Fischer C, Lattrich C, Skrzypczak M, Malik E, Ortmann O, Treeck O: Endometrial expression of estrogen receptorβand its splice variants in patients with and without endometriosis. Arch Gynecol Obstet 2011; 284:885-891.
16. Noyes RW, Hertig AT, Rock J: Dating the endometrial biopsy. Am J Obstet Gynecol 1975; 122:262-263.
17. Donnez J, Smoes P, Gillerot S, Casanas-Roux F, Nisolle M: Vascular endothelial growth factor(VEGF) in endometriosis. Hum Reprod 1998; 13:1686-1690.
18. Krikun G, Hu Z, Osteen K, Bruner-Tran KL, Schatz F, Taylor HS, Toti P, Arcuri F, Konigsberg W, Garen A, Booth CJ, Lockwood CJ: The immunoconjugate "icon" targets aberrantly expressed endothelial tissue factor causing regression of endometriosis. Am J Pathology 2010; 176:1050-1056.
19. Osuga Y, Hirota Y, Taketani Y: Basic and translational research on immunoreactivityase- activated receptors: immunoreactivityase-activated receptors in female reproductive tissues and endometriosis. J Pharmacol Sci 2008; 108:422-425.
20. Krikun G, Lockwood CJ, Paidas MJ: Tissue factor and the endometrium: from physiology to pathology. Thromb Res 2009; 124:393-396.
21. Pawlinski R, Pedersen B, Erlich J, Mackman N: Role of tissue factor in haemostasis, thrombosis, angiogenesis and inflammation: lessions from low tissue factor mice. Thromb Haemost 2004; 92:444-450.
22. Camerer E, Trejo J: Cryptic message: is noncoagulant tissue factor reserved for cell signaling? Proc Natl Acad Sci U S A 2006; 103:14259-14260.
23. Lim SY, Tennant GM, Kennedy S, Wainwright CL, Kane KA: Activation of mouse protease- activated receptor-2 induces lymphocyte adhesion and generation of reactive oxygen species. Br J Pharmacol 2006; 149:591-599.
24. Lindner JR, Kahn ML, Coughlin SR, Sambrano GR, Schauble E, Bernastein D, Foy D, Hafezi-Moghadam A, Ley K: Delayed onset of inflammation in protease-activated receptor- 2-deficient mice. J Immunol 2000; 165:6504-6510.
25. Sampson JA: Peritoneal endometriosis due to the menstrual dissemination of endometrial tissue into the peritoneal cavity. Am J Obstet Gynecol 1927; 14:422-469.
26. Deroo BJ, Korach KS: Estrogen receptors and human disease. J Clin Invest 2006; 116:561-570.
27. Cakmak H, Guzeloglu-Kayisli O, Kayisli UA, Arici A: Immune-endocrine interactions in endometriosis. Front Biosci(Elite Ed) 2009; 1:429-443.
28. Mu L, Zheng W, Wang L, Chen XJ, Zhang X, Yang JH: Alteration of focal adhesion kinase expression in eutopic endometrium of women with endometriosis. Fertil steril 2008; 89:529-537.
29. Carvalho L, Podgaec S, Bellodi-Privato M, Falcone T, Abrão MS: Role of eutopic endometrium in pelvic endometriosis. J Minim Invasive Gynecol 2011; 18:419-427.
30. Abu-Asab M, Zhang M, Amini D, Abu-Asab N, Amri H: Endometriosis gene expression heterogeneity and biosignature: a phylogenetic analysis. Obstet Gynecol Int 2011; 2011:719059.
31. Hirota Y, Osuga Y, Hirata T, Koga K, Yoshino O, Harada M, Morimoto C, Nose E, Yano T, Tsutsumi O, Taketani Y: Evidence for the presence of protease-activated receptor 2 and its possible implication in remodeling of human endometrium. J Clin Endocrinol Metab 2005; 90:1662-1669.